AKT1 and hepatocellular carcinoma: Intriguingly, CD49b activates the AKT pathway in esophageal squamous cell carcinoma and hepatocellular carcinoma (Huang et al., 2021; Juratli et al., 2022), suggesting a mechanistic link between the antigen and a correlated signaling network.